Keith Lynn Wycoff

Title: Keith Lynn Wycoff: Innovator in Immunoadhesin Technology

Introduction

Keith Lynn Wycoff is a notable inventor based in Palo Alto, California. He has made significant contributions to the field of biotechnology, particularly in the development of immunoadhesins. His work focuses on innovative solutions for treating viral infections, specifically those caused by rhinoviruses.

Latest Patents

Wycoff holds a patent for an immunoadhesin comprising a chimeric ICAM-1 molecule produced in a plant. This invention is particularly useful in treating rhinovirus infections. The immunoadhesins contain a chimeric ICAM molecule, which may also include J chain and secretory compounds. The chimeric ICAM molecule is a fusion protein that links a rhinovirus receptor protein to an immunoglobulin protein. This invention also introduces an improved method of producing immunoadhesins in plants, allowing for efficient and economical production. The method involves producing each component of the immunoadhesin in a plant cell, where they assemble. This innovative approach also contemplates the production of immunoadhesins in various eukaryotic cells, including both plants and mammalian cells. The immunoadhesins developed through this invention are aimed at providing therapeutic solutions against the common cold in humans.

Career Highlights

Wycoff is associated with Planet Biotechnology Inc., where he continues to advance his research and development efforts. His work has positioned him as a key figure in the biotechnology sector, particularly in the area of viral infection treatment.

Collaborations

One of his notable collaborators is James W. Larrick, with whom he has worked on various projects related to immunoadhesin technology.

Conclusion

Keith Lynn Wycoff's innovative contributions to biotechnology, particularly through his patent on immunoadhesins, highlight his commitment to advancing therapeutic solutions for viral infections. His work continues to impact the field positively.